WCN25-3504 KIM-1-dependent downregulation of DNase-I drives AKI-to-CKD transition

WCN25-3504 KIM-1-dependent downregulation of DNase-I drives AKI-to-CKD transition

Saved in:

Bibliographic Details
Main Authors:	Lakshman Gunaratnam, Elena Tutunea-Fatan, Shabitha Arumugarajah
Format:	Article
Language:	English
Published:	Elsevier 2025-02-01
Series:	Kidney International Reports
Online Access:	http://www.sciencedirect.com/science/article/pii/S2468024924021764
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

WCN25-403 THIRTY DAYS OUTCOMES OF SUSTAINED LOW EFFICIENCY DIALYSIS IN CRITICALLY ILL PATIENTS OF AKI AND ACUTE ON CKD
by: MD.MAHBOOB ALAM, et al.
Published: (2025-02-01)

Crosstalk between macrophages and adjacent cells in AKI to CKD transition
by: Yanping Lin, et al.
Published: (2025-12-01)

WCN25-1136 FRAILTY IN CKD
by: Beatriz Mendes, et al.
Published: (2025-02-01)

WCN24-1016 MINCLE RECEPTOR IN MACROPHAGE AND NEUTROPHIL CONTRIBUTES TO THE UNRESOLVED INFLAMMATION DURING THE TRANSITION FROM AKI TO CKD
by: Cui Wang, et al.
Published: (2024-04-01)

WCN25-4212 THE IMPACT OF RHABDOMYOLYSIS INDUCED AKI ON PATIENT OUTCOMES
by: k sai sindhu singh, et al.
Published: (2025-02-01)

Depletion of macrophages with clodronate liposomes partially attenuates renal fibrosis on AKI–CKD transition
by: Zhizhi Hu, et al.
Published: (2023-12-01)

WCN25-3928 VARIED MANIFESTATIONS AND ASSOCIATIONS OF LEPTOSPIRA AKI - CLINICAL AND HISTOPATHOLOGICAL ANALYSIS
by: Mahendra Atlani, et al.
Published: (2025-02-01)

WCN24-1970 CD11b deficiency ameliorates AKI-to-CKD progress via promoting alternative activation of macrophages
by: Yiqin Shi, et al.
Published: (2024-04-01)

Protein lactylation of citrate synthase promotes the AKI-CKD transition by activating the NLRP3 inflammasome
by: Fang Yu, et al.
Published: (2025-08-01)

Research progress on the role of G2/M cell cycle arrest in the AKI-CKD transition
by: LIU Shui-ying, et al.
Published: (2020-01-01)

WCN25-1690 CODESIGNING AN INFORMATION WEBSITE FOR CKD PATIENTS : RENACLIC
by: corinne isnard bagnis, et al.
Published: (2025-02-01)

WCN25-4537 ORAL MANIFESTATIONS IN CHRONIC KIDNEY DISEASES(CKD)
by: Padmini Sirkanungo, et al.
Published: (2025-02-01)

WCN25-1422 STUDY OF BIOMARKERS PREDICTIVE IN SNAKEBITE AKI (SAKI) TO CHRONIC KIDNEY DISEASE
by: PINAKI MUKHOPADHYAY, et al.
Published: (2025-02-01)

WCN25-3936 PREVALENCE, ASSOCIATED FACTORS, AND PROGNOSTIC OF AKI IN MALARIA IN SUB-SAHARAN AFRICANS
by: Mansour Mbengue, et al.
Published: (2025-02-01)

Integrated multiomics analysis identifies potential biomarkers and therapeutic targets for autophagy associated AKI to CKD transition
by: Yaojun Wang, et al.
Published: (2025-04-01)

The critical role of ion channels in kidney disease: perspective from AKI and CKD
by: Chen sui zi Li, et al.
Published: (2025-12-01)

WCN25-3834 IMPACT OF DIETARY INTERVENTION ON QUALITY OF LIFE OUTCOMES IN STAGE 3, 4, AND NON DIALYSIS 5 CKD PATIENTS
by: HIMANSU MAHAPATRA, et al.
Published: (2025-02-01)

WCN25-1369 BURDEN AND OUTCOMES OF CKD IN PATIENTS PRESENTING WITH HYPERTENSIVE CRISIS
by: Yelavarthy Yeshwanth Mohan, et al.
Published: (2025-02-01)

WCN25-84 ROLE OF DESIDUSTAT IN ANEMIC CKD-EASTERN INDIA EXPERIENCE
by: Rohit Rungta
Published: (2025-02-01)

WCN25-152 HYDRATION: How Much is Suitable in Every CKD Stage?
by: Dmytro Ivanov, et al.
Published: (2025-02-01)

WCN25-2411 COMMUNITY ACQUIRED AKI ETIOLOGICAL SPECTRUM IN TERTIARY CARE HOSPITAL IN SOUTHERN RAJASTHAN
by: TARESHWAR KUMAR
Published: (2025-02-01)

WCN25-2609 PREDICTOR AND LONG- TERM OUTCOME OF SNAKEBITE ASSOCIATED AKI(SAKI) IN EASTERN INDIA
by: Baishali Banerjee, et al.
Published: (2025-02-01)

WCN24-1335 PIRFENIDONE DOWNREGULATES RENAL FIBROGENESIS AND INFLAMMATION SLOWING CKD PROGRESSION IN AN EXPERIMENTAL MODEL OF HYPERTENSIVE NEPHROSCLEROSIS
by: ANA LAURA RUBIO FRANCINI, et al.
Published: (2024-04-01)

WCN25-2306 THE BURDEN OF TRAVELLING DISTANCE TO THE DIALYSIS CENTRE ON CKD PATIENTS IN INDIA
by: Deepa Usulumarty, et al.
Published: (2025-02-01)

WCN25-1900 Clinical and Safety Outcomes of Semaglutide by CKD Severity in the FLOW trial
by: Katherine Tuttle, et al.
Published: (2025-02-01)

WCN25-3917 CKD IN HIGH-ENDEMIC REGIONS: COMMUNITY INSIGHTS FROM SELF-REPORTED, NEWLY DIAGNOSED, AND NON-CKD RESIDENTS
by: Kavita Yadav, et al.
Published: (2025-02-01)

WCN25-136 IMPROVE KIDNEY CARE: PERSPECTIVES FROM PEOPLE WITH CKD AND RISK FACTORS FOR CKD ON ACCESS TO AND EXPERIENCE OF NEPHROLOGY SERVICES
by: Rebekah Grace Cheung Judge, et al.
Published: (2025-02-01)

Dental biofilms contain DNase I-resistant Z-DNA and G-quadruplexes but alternative DNase overcomes this resistance
by: Dominique C. S. Evans, et al.
Published: (2025-05-01)

Microglial double stranded DNA accumulation induced by DNase II deficiency drives neuroinflammation and neurodegeneration
by: Ling-jie Li, et al.
Published: (2025-01-01)

WCN25-2759 INCIDENCE, RISK FACTORS AND OUTCOMES OF AKI AMONG PATIENTS IN A TERTIARY HOSPITAL IN SOUTHEAST NIGERIA
by: Chinedu Udeze, et al.
Published: (2025-02-01)

WCN25-2405 A STUDY OF TROPICAL FEVER INDUCED AKI IN A TERTIARY CARE CENTRE OF SOUTHERN RAJASTHAN
by: TUSHAR TYAGI
Published: (2025-02-01)

WCN25-1428 DIASTOLIC DYSFUNCTION IS ASSOCIATED WITH INCREASED RISK OF AKI: A POCUS APPLICATION IN PATIENTS WITH COVID-19
by: Yannick Nlandu, et al.
Published: (2025-02-01)

WCN25-2509 GENETIC VARIANTS ASSOCIATED WITH CHRONIC KIDNEY DISEASE (CKD) IN AN INDIAN POPULATION
by: Mythri Shankar, et al.
Published: (2025-02-01)

WCN25-4045 FINANCIAL CHAINS AND MENTAL STRAIN: THE TRUE COST OF HAEMODIALYSIS FOR CKD PATIENTS
by: Mohit Naredi, et al.
Published: (2025-02-01)

PRDM16 acts as a homeostasis regulation factor to suppress the transition of AKI to CKD via upregulation of eukaryotic initiation factor 6
by: Xiaozhou Li, et al.
Published: (2025-06-01)

WCN25-1595 ORAL HEALTH ASSESSMENT IN CHRONIC KIDNEY DISEASE (CKD) PATIENTS ON MAINTENANCE HEMODIALYSIS
by: Akash Rana, et al.
Published: (2025-02-01)

WCN25-3776 CAN WE IMPROVE ACCURACY OF DIAGNOSING IRON DEFICIENCY AMONG CKD PATIENTS?
by: Nageshwar Panchal, et al.
Published: (2025-02-01)

WCN25-2199 Is there a role for substituting non-vasodilatory beta-blockers in managing hypertension in CKD ?
by: Sayali Kondkar, et al.
Published: (2025-02-01)

WCN25-4211 A COMPARATIVE STUDY OF DESIDUSTAT AND ERYTHROPOIETIN STIMULATING AGENTS IN CKD-RELATED ANEMIA
by: Gaurav Modi, et al.
Published: (2025-02-01)

WCN25-3972 THE SILENT THREAT: CAN BATTERIES DISCHARGE YOUR KIDNEYS? – A CASE REPORT ON AKI DUE TO OCCUPATIONAL EXPOSURE
by: Anurag Pattanaik, et al.
Published: (2025-02-01)